Search - tctmd.com

Displaying 41 - 50 of 50

Sort: Relevancy | Date

News Daily News

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

Yael L. Maxwell

May 21, 2020

News Daily News

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

Michael O'Riordan

May 05, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for May

Todd Neale

May 01, 2020

News Daily News

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

Caitlin E. Cox

April 24, 2020

News Daily News

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

Todd Neale

March 17, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for March

Todd Neale

March 01, 2020

News Conference News ESC 2019

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Yael L. Maxwell

September 04, 2019

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

Partner Content

COVID-19 TCTMD HUB

July 17, 2020

Advertisement

No Worse COVID-19 Prognosis With ACE Inhibitors, ARBs: ‘Living’ Review Suggests

COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk

COVID-19: TCTMD’s Daily Dispatch for May

ACE Inhibitors/ARBs Safe, Possibly Protective in Hypertensive COVID-19 Patients

COVID-19 Should Not Guide Use of ACE Inhibitors/ARBs, Heart Societies Say

COVID-19: TCTMD’s Daily Dispatch for March

Long-term Secondary Prevention Post-CABG Important Yet Lacking: SWEDEHEART

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

COVID-19 TCTMD HUB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content